JP2000312598A - Synthesis of new capsaicinoid-like substance - Google Patents
Synthesis of new capsaicinoid-like substanceInfo
- Publication number
- JP2000312598A JP2000312598A JP11123474A JP12347499A JP2000312598A JP 2000312598 A JP2000312598 A JP 2000312598A JP 11123474 A JP11123474 A JP 11123474A JP 12347499 A JP12347499 A JP 12347499A JP 2000312598 A JP2000312598 A JP 2000312598A
- Authority
- JP
- Japan
- Prior art keywords
- aliphatic hydrocarbon
- capsaicinoid
- hydrocarbon group
- substance
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規のカプサイシ
ノイド様物質の合成法に関するものである。The present invention relates to a method for synthesizing a novel capsaicinoid-like substance.
【0002】[0002]
【従来の技術】トウガラシ(Capsicum annuum L.)は、
食品、香辛料及び医薬品原料として世界中で広く利用さ
れている植物であり、その辛味成分はカプサイシン
((E)-N-[(4-hydroxy-3-methoxyphenyl)-methyl]-8-m
ethyl-6-nonenamide)、ジヒドロカプサイシン、即ち、
カプサイシンの6, 7-ジヒドロ誘導体などである。しか
し、これらカプサイシン等は肥満抑制作用等の生理活性
があるにも拘わらず、辛味及び侵襲性が強いためにその
使用量等が制限され、食品添加物又は医薬品としての用
途はかなり限られたものであった。近年、辛味のないカ
プサイシノイド様物質が多量に含まれている無辛味固定
品種トウガラシ「CH-19甘」が報告されている(Yazawa,
S.; Suetome, N.; Okamoto, K.; Namiki, T., J. Japa
n Soc. Hort. Sci., 1989, 58, 601-607)。この辛味の
ないカプサイシノイド様物質は以下の化学式を有してい
る。2. Description of the Related Art Pepper (Capsicum annuum L.)
It is a plant widely used worldwide as a food, spice and pharmaceutical ingredient, and its pungent component is capsaicin ((E) -N-[(4-hydroxy-3-methoxyphenyl) -methyl] -8-m
ethyl-6-nonenamide), dihydrocapsaicin, ie
And 6,7-dihydro derivatives of capsaicin. However, despite the fact that these capsaicins and the like have physiological activities such as an obesity-suppressing action, their use is limited due to their strong pungency and invasiveness, and their use as food additives or pharmaceuticals is quite limited. Met. In recent years, a non-pungent fixed cultivar "CH-19 sweet" containing a large amount of capsaicinoid-like substances without pungency has been reported (Yazawa,
S .; Suetome, N .; Okamoto, K .; Namiki, T., J. Japa
n Soc. Hort. Sci., 1989, 58, 601-607). This non-pungent capsaicinoid-like substance has the following chemical formula:
【0003】[0003]
【化3】 Embedded image
【0004】[0004]
【発明が解決しようとする課題】これらの辛味のない新
規カプサイシノイド様物質は辛味がないために医薬品又
は食品添加物として利用できる可能性があるが、植物か
ら取得する場合にはその生産量に限界があった。These novel non-pungent capsaicinoid-like substances have the potential to be used as pharmaceuticals or food additives because of their lack of pungency, but when obtained from plants, their production is limited. was there.
【0005】本発明はかかる課題を解決すべく、安価に
しかも短時間に新規カプサイシノイド様物質を大量生産
するための合成法を開発すべくなされたものである。[0005] In order to solve the above problems, the present invention has been made to develop a synthesis method for mass-producing a novel capsaicinoid-like substance at a low cost in a short time.
【0006】[0006]
【課題を解決するための手段】本発明者らは化学合成で
はなく、酵素、特にエステラーゼの一種であるリパーゼ
を用いる生化学的合成法を確立して上記課題を解決し、
本発明を完成した。即ち、本発明は、リパーゼ等の酵素
を用いることを特徴とする、一般式(I):Means for Solving the Problems The present inventors have solved the above problems by establishing a biochemical synthesis method using enzymes, particularly lipase, which is a kind of esterase, instead of chemical synthesis.
The present invention has been completed. That is, the present invention uses an enzyme such as lipase, and is characterized by general formula (I):
【0007】[0007]
【化4】 Embedded image
【0008】(式中、Rは脂肪族炭化水素基を示す。)
で表される新規なカプサイシノイド様物質の合成法に係
る。本発明は特に、 酵素としてリパーゼを使用し、一
般式(II):(Wherein, R represents an aliphatic hydrocarbon group)
The present invention relates to a method for synthesizing a novel capsaicinoid-like substance represented by the formula: The present invention particularly uses lipase as the enzyme and has the general formula (II):
【0009】[0009]
【化5】 Embedded image
【0010】(式中、R、R1、R2、及びR3、並び
にR’は脂肪族炭化水素基を示し、R1、R2、及びR
3のうちの少なくともひとつはRに等しい。)で表され
る脂肪酸エステル、トリアシルグリセリド及び脂肪酸の
うちの少なくとも一種とバニリルアルコールを基質とし
て用い、リパーゼの逆反応を利用することを特徴とす
る、上記カプサイシノイド様物質の合成法に係る。上記
一般式(I)及び(II)において、R、R1、R
2、及びR3は直鎖状又は分岐状であり、飽和又は不飽
和の脂肪族炭化水素基である。Rとしては、直鎖状飽和
脂肪族炭化水素又は分岐状不飽和脂肪族炭化水素基が好
ましい。又、これらの脂肪族炭化水素基に含まれる炭素
数に特に制限はなく、例えば、5乃至17の範囲であり
得る。一般式(II)における脂肪酸エステルのR’
は、例えば、メチル及びエチル等のアルキル基が好適で
ある。尚、バニリルアルコール以外の基質としては、脂
肪酸エステルが収率及びカプサイシノイド様物質の精製
の点で好ましい。又、本発明の合成法において基質とし
て使用する脂肪酸は、エステラーゼによる脂肪酸エステ
ル又はトリアシルグリセリドの加水分解によってその場
で生じたものであり得る。Wherein R, R1, R2, and R3, and R ′ each represent an aliphatic hydrocarbon group;
At least one of the three is equal to R. The present invention relates to a method for synthesizing the above capsaicinoid-like substance, characterized in that at least one of the fatty acid ester, triacylglyceride and fatty acid represented by the formula (1) and vanillyl alcohol are used as substrates and a reverse reaction of lipase is utilized. In the above general formulas (I) and (II), R, R1, R
2 and R3 are linear or branched and are a saturated or unsaturated aliphatic hydrocarbon group. R is preferably a linear saturated aliphatic hydrocarbon or a branched unsaturated aliphatic hydrocarbon group. Further, the number of carbon atoms contained in these aliphatic hydrocarbon groups is not particularly limited, and may be, for example, in the range of 5 to 17. R ′ of the fatty acid ester in the general formula (II)
Is preferably an alkyl group such as methyl and ethyl. As a substrate other than vanillyl alcohol, a fatty acid ester is preferable in terms of yield and purification of a capsaicinoid-like substance. The fatty acid used as a substrate in the synthesis method of the present invention may be one generated in situ by hydrolysis of a fatty acid ester or triacylglyceride by esterase.
【0011】本発明の合成法で使用する酵素としては、
例えば、エステラーゼ、特に、リパーゼを使用するこ
とが好ましい。リパーゼはエステラーゼの一種で、脂肪
酸のグリセリンエステルである脂肪の加水分解に関与す
る酵素であり、動植物及び微生物に広く分布している。
本発明の合成法においては、使用する酵素の生物源に関
して特に制限はなく、例えば、リパーゼであれば、菌類
及び動植物等由来のものを好適に使用することが出来
る。更に、本発明の合成法においては、反応効率及び経
済的観点から、かかる酵素を適当な担体に結合させて得
られる固定化酵素を使用することが好ましい。これらの
酵素を固定化する各種技術は当業者には公知であり、
又、各種の固定化酵素、例えば、固定化リパーゼが市販
されているため、当業者はこれらを容易に入手すること
も出来る。The enzymes used in the synthesis method of the present invention include:
For example, it is preferable to use esterases, especially lipases. Lipase is a type of esterase, an enzyme involved in the hydrolysis of fats, which are glycerin esters of fatty acids, and is widely distributed in animals, plants and microorganisms.
In the synthesis method of the present invention, there is no particular limitation on the biological source of the enzyme to be used. For example, a lipase derived from fungi, animals and plants, and the like can be suitably used. Furthermore, in the synthesis method of the present invention, it is preferable to use an immobilized enzyme obtained by binding such an enzyme to an appropriate carrier from the viewpoint of reaction efficiency and economical efficiency. Various techniques for immobilizing these enzymes are known to those skilled in the art,
In addition, since various immobilized enzymes, for example, immobilized lipase are commercially available, those skilled in the art can easily obtain them.
【0012】本発明の合成法において使用する酵素の種
類・量・生物源、及び基質の種類・量等は当業者が適宜
選択することが出来、更に、反応温度・時間・pH、反
応溶媒等の諸条件もこれらに応じて当業者が適宜設定す
ることが出来る。合成後に、例えば、シリカゲルカラム
等のような適当な公知手段によって、得られたカプサイ
シノイド様物質を精製することができる。The type and amount of the enzyme used in the synthesis method of the present invention, the biological source, and the type and amount of the substrate can be appropriately selected by those skilled in the art. Further, the reaction temperature, time, pH, reaction solvent, etc. Those skilled in the art can appropriately set the various conditions described above. After the synthesis, the obtained capsaicinoid-like substance can be purified by a suitable known means such as a silica gel column.
【0013】[0013]
【発明の実施の形態】以下、本発明を実施例により説明
するが、本発明はこれら実施例に限定されるものではな
い。尚、以下の実施例において、合成された化合物の構
造は、高分解マススペクトル、赤外線吸収スペクトル、
紫外線吸収スペクトル、及び核磁気共鳴スペクトルによ
って同定した。DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, the present invention will be described with reference to examples, but the present invention is not limited to these examples. Incidentally, in the following examples, the structure of the synthesized compound has a high-resolution mass spectrum, an infrared absorption spectrum,
It was identified by an ultraviolet absorption spectrum and a nuclear magnetic resonance spectrum.
【0014】[0014]
【実施例】〔実施例1〕カプシエイトの合成 1グラムのカプサイシン(Sigma, M-2028, 純度98%)を
4規定含水メタノール性塩酸750 ml(濃塩酸250 mlにメ
タノール500 mlを混合したもの)で45時間環流した。石
油エーテルで3回抽出し、0.1 規定塩酸で2回洗浄、硫酸
ナトリウムで脱水し、溶媒を留去して、脂肪酸メチル56
0 mgを得た。収率は92.9%と高率であった。このように
して得られた脂肪酸メチル560 mg(3.04 mmol, 終濃
度;40 mM)と11.7 gのバニリルアルコール(76.0 mmo
l)を76 mlの1,4-dioxaneに溶かし、3.0gの固定化リパ
ーゼ(Novozym435:Novo Nordisk製)を加えて、60℃で
30分間反応させた。反応終了後、ガラスフィルターでNo
vozym435を除き、ろ液にヘキサンを加えて、過剰のバニ
リルアルコールを沈殿させて除き、化合物を回収した。
溶媒を留去して化合物の重量を測定したところ、974 mg
であった。次いで、得られた化合物から、シリカゲル30
gを内径3.5 cmのカラムに充填したカラムを用いてカプ
シエイトの精製を行った。得られた化合物をヘキサンと
酢酸エチルの溶離液(10:1)で精製し、最終的にカプ
サイシノイド様物質であるカプシエイト561 mgを得た。
収量は60.1%と高く、純度は95%と高純度であった。
尚、収率及び純度は以下の条件でのHPLC測定によっ
て、標準物質を用いて得られた面積を100%として、
それと精製した物質から得られた面積との比から計算し
て求めた。 HPLC条件: カラム:5C18 wakosil AR (直径4.6mm x 15
0mm) 溶離液:85%メタノール 流速 :0.5ml/min 検出 :蛍光 EX280nm EM320nmEXAMPLES Example 1 Synthesis of Capsiate 1 gram of capsaicin (Sigma, M-2028, 98% purity)
The mixture was refluxed for 45 hours with 750 ml of 4N aqueous methanolic hydrochloric acid (a mixture of 250 ml of concentrated hydrochloric acid and 500 ml of methanol). Extract three times with petroleum ether, wash twice with 0.1 N hydrochloric acid, dehydrate with sodium sulfate, evaporate the solvent,
0 mg was obtained. The yield was as high as 92.9%. The thus obtained fatty acid methyl ester 560 mg (3.04 mmol, final concentration; 40 mM) and 11.7 g of vanillyl alcohol (76.0 mmo)
l) was dissolved in 76 ml of 1,4-dioxane, and 3.0 g of immobilized lipase (Novozym435: manufactured by Novo Nordisk) was added.
The reaction was performed for 30 minutes. After the reaction is completed,
Excluding vozym435, hexane was added to the filtrate to remove excess vanillyl alcohol by precipitation, and the compound was recovered.
The solvent was distilled off, and the weight of the compound was measured.
Met. Next, silica gel 30
The capsiate was purified using a column packed with g in a column having an inner diameter of 3.5 cm. The obtained compound was purified with an eluent of hexane and ethyl acetate (10: 1) to finally obtain 561 mg of capsaicin, a capsaicinoid-like substance.
The yield was as high as 60.1% and the purity was as high as 95%.
The yield and purity were determined by HPLC measurement under the following conditions, with the area obtained using the standard substance as 100%.
It was calculated and calculated from the ratio of the area obtained from the purified material. HPLC conditions: Column: 5C18 wakosil AR (4.6 mm diameter x 15
0 mm) Eluent: 85% methanol Flow rate: 0.5 ml / min Detection: fluorescence EX280 nm EM320 nm
【0015】〔実施例2〕反応時間及び反応温度の検討 バニリルアルコール7.7 mg(50μmol)とノナン酸メチ
ル1.0μl(5 μmol)を基質として、1,4-Dioxane500μl
を反応溶媒とし、固定化リパーゼNovozym435を20 mg用
いて、カプサイシノイド様物質であるバニリルノナノエ
イトの酵素的合成を行い、反応時間及び反応温度の検討
を行った。尚、合成した化合物の精製は実施例1と同様
に行った。その結果、図1に示したように60℃で30分間
反応させた条件が収量的に最も高く、60%以上の収量で
あった。Example 2 Investigation of reaction time and reaction temperature Using vanillyl alcohol 7.7 mg (50 μmol) and methyl nonanoate 1.0 μl (5 μmol) as a substrate, 1,4-dioxane 500 μl
Was used as a reaction solvent, and enzymatic synthesis of a capsaicinoid-like substance, vanillyl nonanoate, was performed using 20 mg of immobilized lipase Novozym435, and the reaction time and reaction temperature were examined. The purified compound was purified in the same manner as in Example 1. As a result, as shown in FIG. 1, the reaction at 60 ° C. for 30 minutes was the highest in terms of yield, with a yield of 60% or more.
【0016】〔実施例3〕種々の脂肪酸メチルを用いたカプサイシノイド様物質の
大量合成 実施例2のノナン酸メチル(脂肪族炭化水素基であるR
に含まれる炭素数:8)に代えて、カプリル酸(オクタ
ン酸)メチル(脂肪族炭化水素基であるRに含まれる炭
素数:7)、カプリン酸(デカン酸)メチル(脂肪族炭
化水素基であるRに含まれる炭素数:9)、ヘキサン酸
メチル(脂肪族炭化水素基であるRに含まれる炭素数:
5)、ラウリン酸メチル(脂肪族炭化水素基であるRに
含まれる炭素数:11)、ステアリン酸メチル(脂肪族
炭化水素基であるRに含まれる炭素数:17)及びミリ
スチン酸メチル(脂肪族炭化水素基であるRに含まれる
炭素数:13)を用いてカプサイシノイド様物質の酵素
的合成を行った。また、本実施例ではスケールを上げ
て、バニリルアルコール7.7 g(50 mmol)と上記各脂肪
酸メチル(2.5 mmol)を基質として、1,4-Dioxane50 ml
を反応溶媒とし、固定化リパーゼNovozym435を2 g用い
て60℃で30分間振盪し反応させた。尚、合成した化合物
の精製は実施例1と同様に行った。その結果、表1に示
したように各種のカプサイシノイド様物質が約30〜77%
と高い収率が得られた。Example 3 Capsaicinoid-like substance using various fatty acid methyls
Mass Synthesis of Methyl Nonanoate of Example 2 (R is an aliphatic hydrocarbon group)
(Carbon number contained in R which is an aliphatic hydrocarbon group: 7) and methyl caprate (decanoic acid) methyl (aliphatic hydrocarbon group) And the number of carbon atoms contained in methyl hexanoate (an aliphatic hydrocarbon group R):
5), methyl laurate (the number of carbon atoms contained in R as the aliphatic hydrocarbon group: 11), methyl stearate (the number of carbon atoms contained in R as the aliphatic hydrocarbon group: 17), and methyl myristate (the fat) An enzymatic synthesis of a capsaicinoid-like substance was performed using the number of carbon atoms contained in R which is a group hydrocarbon group: 13). Further, in this example, the scale was raised, and using 7.7 g (50 mmol) of vanillyl alcohol and each of the above fatty acid methyl (2.5 mmol) as substrates, 50 ml of 1,4-Dioxane was used.
Was used as a reaction solvent, and 2 g of immobilized lipase Novozym435 was shaken at 60 ° C. for 30 minutes to react. The purified compound was purified in the same manner as in Example 1. As a result, as shown in Table 1, various capsaicinoid-like substances contained about 30 to 77%
And a high yield was obtained.
【0017】[0017]
【表1】 [Table 1]
【0018】〔実施例4〕基質の検討 ノナン酸メチルに代えてトリノナノインを用いて、実施
例2と同様にバニリルノナノエイトを合成した。尚、合
成した化合物の精製は実施例1と同様に行った。その結
果、表2に示したように、最適条件下ではトリノナノイ
ンを用いた場合(90分間の反応で約46及び約50%の収
量)のほうが、ノナン酸メチルを用いた場合(15分間の
反応で約40%の収量)よりも収量が高かった。しかし、
トリノナノインの場合には反応時間を延長する必要があ
った。Example 4 Examination of Substrate Vanillyl nonanoate was synthesized in the same manner as in Example 2 except that trinonanoin was used instead of methyl nonanoate. The purified compound was purified in the same manner as in Example 1. As a result, as shown in Table 2, under the optimal conditions, the case where trinonanoin was used (a yield of about 46 and about 50% in a reaction for 90 minutes) was better than the case where methyl nonanoate was used (15 minutes). Yield of about 40%). But,
In the case of trinonanoin, the reaction time had to be extended.
【0019】[0019]
【表2】 [Table 2]
【0020】尚、基質として過剰に用いるバニリルアル
コールは、ヘキサンで沈殿させることにより使用量の90
%程度は回収可能であり、再利用することができた。更
に、固定化リパーゼ(Novozym435)は繰り返し利用して
も顕著な活性の低下は認められず、少なくても10回以上
再利用することができた。The excess amount of vanillyl alcohol used as a substrate is reduced to 90% by precipitation with hexane.
About% was recoverable and could be reused. Furthermore, the immobilized lipase (Novozym435) did not show a remarkable decrease in activity even when repeatedly used, and could be reused at least 10 times or more.
【0021】[0021]
【発明の効果】本発明により、安価にしかも短時間で高
収量に新規カプサイシノイド様物質を大量生産すること
ができる。According to the present invention, a novel capsaicinoid-like substance can be mass-produced inexpensively and in a short time and in high yield.
【図1】種々の反応温度でのバニリルノナノエイト合成
における反応時間と収量との関係。FIG. 1. Relationship between reaction time and yield in the synthesis of vanillyl nonanoate at various reaction temperatures.
─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成12年4月26日(2000.4.2
6)[Submission date] April 26, 2000 (200.4.2
6)
【手続補正1】[Procedure amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】特許請求の範囲[Correction target item name] Claims
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【特許請求の範囲】[Claims]
【化1】 で表される新規なカプサイシノイド様物質の合成法であ
って、一般式(II):Embedded image A method for synthesizing a novel capsaicinoid-like substance represented by the general formula (II):
【化2】 (上記式(I)及び(II)中、R1、R2、及びR
3、並びにR’は脂肪族炭化水素基を示し、Rは炭素数
が5乃至17である脂肪族炭化水素基を示し、R1、R
2、及びR3のうちの少なくともひとつはRに等し
い。)で表される脂肪酸エステル、トリアシルグリセリ
ド及び脂肪酸のうちの少なくとも一種とバニリルアルコ
ールを基質として用い、リパーゼの逆反応を利用するこ
とを特徴とする、前記合成法。Embedded image (In the above formulas (I) and (II), R1, R2 and R
3, and R ′ represent an aliphatic hydrocarbon group; R represents an aliphatic hydrocarbon group having 5 to 17 carbon atoms;
2, and at least one of R3 is equal to R. )) Wherein at least one of the fatty acid ester, triacylglyceride and fatty acid represented by formula (1) and vanillyl alcohol are used as substrates, and the reverse reaction of lipase is used.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 今井 正武 神奈川県横浜市鶴見区下末吉2−1−1 森永製菓株式会社研究所内 (72)発明者 加藤 正俊 神奈川県横浜市鶴見区下末吉2−1−1 森永製菓株式会社研究所内 (72)発明者 橋爪 秀一 神奈川県横浜市鶴見区下末吉2−1−1 森永製菓株式会社研究所内 Fターム(参考) 4B064 AD64 AD68 CA21 CA31 CD06 CD07 CD12 CD22 CE10 DA16 ────────────────────────────────────────────────── ─── Continued on the front page (72) Inventor Masatake Imai 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, Kanagawa Prefecture Inside Morinaga Confectionery Co., Ltd. (72) Inventor Masatoshi Kato 2- Shimosueyoshi, Tsurumi-ku, Yokohama-shi, Kanagawa 1-1 Morinaga Confectionery Co., Ltd. (72) Inventor Shuichi Hashizume 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, Kanagawa Prefecture Morinaga Confectionery Co., Ltd. F-term (reference) 4B064 AD64 AD68 CA21 CA31 CD06 CD07 CD12 CD22 CE10 DA16
Claims (7)
(I): 【化1】 (式中、Rは脂肪族炭化水素基を示す。)で表される新
規なカプサイシノイド様物質の合成法。1. A compound of the general formula (I), wherein an enzyme is used. (Wherein R represents an aliphatic hydrocarbon group). A method for synthesizing a novel capsaicinoid-like substance represented by the formula:
を特徴とする、請求項1に記載の合成法。2. The method according to claim 1, wherein a reverse reaction by an esterase is used.
族炭化水素基を示し、R1、R2、及びR3のうちの少
なくともひとつはRに等しい。)で表される脂肪酸エス
テル、トリアシルグリセリド及び脂肪酸のうちの少なく
とも一種とバニリルアルコールを基質として用い、リパ
ーゼの逆反応を利用することを特徴とする、請求項2に
記載の合成法。3. A compound of the general formula (II): (Wherein, R, R1, R2, and R3, and R ′ each represent an aliphatic hydrocarbon group, and at least one of R1, R2, and R3 is equal to R). The method according to claim 2, wherein at least one of acylglycerides and fatty acids and vanillyl alcohol are used as substrates, and a reverse reaction of lipase is used.
が直鎖状飽和脂肪族炭化水素基であることを特徴とす
る、請求項3に記載の合成法。4. In general formulas (I) and (II),
Is a linear saturated aliphatic hydrocarbon group, The synthesis method according to claim 3, wherein
が分岐状不飽和脂肪族炭化水素基であることを特徴とす
る、請求項3に記載の合成法。5. In general formulas (I) and (II),
Is a branched unsaturated aliphatic hydrocarbon group, The synthesis method according to claim 3, wherein
に含まれる炭素数が5乃至17であることを特徴とす
る、請求項4又は5に記載の合成法。6. In general formulas (I) and (II),
The synthesis method according to claim 4, wherein the number of carbon atoms contained in the compound is 5 to 17.
する、請求項3乃至6のいずれか一項に記載の合成法。7. The synthesis method according to claim 3, wherein an immobilized lipase is used.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11123474A JP3092006B1 (en) | 1999-04-30 | 1999-04-30 | Synthesis method of new capsaicinoid-like substance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11123474A JP3092006B1 (en) | 1999-04-30 | 1999-04-30 | Synthesis method of new capsaicinoid-like substance |
Publications (2)
Publication Number | Publication Date |
---|---|
JP3092006B1 JP3092006B1 (en) | 2000-09-25 |
JP2000312598A true JP2000312598A (en) | 2000-11-14 |
Family
ID=14861533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11123474A Expired - Lifetime JP3092006B1 (en) | 1999-04-30 | 1999-04-30 | Synthesis method of new capsaicinoid-like substance |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3092006B1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005099682A1 (en) * | 2004-03-30 | 2005-10-27 | Kobayashi Pharmaceutical Co., Ltd. | Preparations for external use |
JP2006223233A (en) * | 2005-02-18 | 2006-08-31 | Ajinomoto Co Inc | Method for producing capsinoid, method for stabilizing the same, and capsinoid composition |
JP2007145793A (en) * | 2005-02-01 | 2007-06-14 | Ajinomoto Co Inc | External preparation for promoting blood circulation, and cosmetic for skin and hair, and bathing agent containing the same |
WO2007111276A1 (en) * | 2006-03-24 | 2007-10-04 | Ajinomoto Co., Inc. | Novel ester derivative and use thereof |
WO2007114128A1 (en) | 2006-03-31 | 2007-10-11 | Ajinomoto Co., Inc. | Method for production of capsinoid-containing beverage/food |
WO2007125717A1 (en) | 2006-04-24 | 2007-11-08 | Ajinomoto Co., Inc. | Agent for amelioration of dysphagia, and pharmaceutical or food composition comprising the same |
US7700331B2 (en) | 2005-02-18 | 2010-04-20 | Ajinomoto Co., Inc. | Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition |
WO2010140686A1 (en) | 2009-06-05 | 2010-12-09 | 味の素株式会社 | Emulsifying preparation |
CN101348433B (en) * | 2008-09-03 | 2011-02-09 | 西南大学 | 4-alkoxy-coumarin fatty acid ester, synthetic method and use |
US7943666B2 (en) | 2006-07-24 | 2011-05-17 | Trinity Laboratories, Inc. | Esters of capsaicin for treating pain |
JP2011167072A (en) * | 2010-01-21 | 2011-09-01 | Mitsubishi Rayon Co Ltd | Method for producing ester compound |
US9399030B2 (en) | 2005-02-01 | 2016-07-26 | Ajinomoto Co., Inc. | Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same |
KR20210042013A (en) * | 2019-10-07 | 2021-04-16 | 동국대학교 산학협력단 | Novel preservatives and preparation method thereof |
WO2021071136A3 (en) * | 2019-10-07 | 2021-06-10 | 동국대학교 산학협력단 | Novel preservative, and method for producing same |
-
1999
- 1999-04-30 JP JP11123474A patent/JP3092006B1/en not_active Expired - Lifetime
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005099682A1 (en) * | 2004-03-30 | 2005-10-27 | Kobayashi Pharmaceutical Co., Ltd. | Preparations for external use |
US9399030B2 (en) | 2005-02-01 | 2016-07-26 | Ajinomoto Co., Inc. | Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same |
JP2007145793A (en) * | 2005-02-01 | 2007-06-14 | Ajinomoto Co Inc | External preparation for promoting blood circulation, and cosmetic for skin and hair, and bathing agent containing the same |
EP2716624A1 (en) | 2005-02-18 | 2014-04-09 | Ajinomoto Co., Inc. | Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition |
JP4696588B2 (en) * | 2005-02-18 | 2011-06-08 | 味の素株式会社 | Capsinoid production method and stabilization method, and capsinoid composition |
JP2006223233A (en) * | 2005-02-18 | 2006-08-31 | Ajinomoto Co Inc | Method for producing capsinoid, method for stabilizing the same, and capsinoid composition |
US7700331B2 (en) | 2005-02-18 | 2010-04-20 | Ajinomoto Co., Inc. | Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition |
US8765809B2 (en) | 2006-03-24 | 2014-07-01 | Ajinomoto Co., Inc. | Ester derivative and use thereof |
WO2007111276A1 (en) * | 2006-03-24 | 2007-10-04 | Ajinomoto Co., Inc. | Novel ester derivative and use thereof |
US8212068B2 (en) | 2006-03-24 | 2012-07-03 | Ajinomoto Co., Inc. | Ester derivative and use thereof |
JP5126059B2 (en) * | 2006-03-24 | 2013-01-23 | 味の素株式会社 | Novel ester derivatives and their uses |
WO2007114128A1 (en) | 2006-03-31 | 2007-10-11 | Ajinomoto Co., Inc. | Method for production of capsinoid-containing beverage/food |
WO2007125717A1 (en) | 2006-04-24 | 2007-11-08 | Ajinomoto Co., Inc. | Agent for amelioration of dysphagia, and pharmaceutical or food composition comprising the same |
US7943666B2 (en) | 2006-07-24 | 2011-05-17 | Trinity Laboratories, Inc. | Esters of capsaicin for treating pain |
CN101348433B (en) * | 2008-09-03 | 2011-02-09 | 西南大学 | 4-alkoxy-coumarin fatty acid ester, synthetic method and use |
EP2777805A2 (en) | 2009-06-05 | 2014-09-17 | Ajinomoto Co., Inc. | Emulsifying preparation |
US8669287B2 (en) | 2009-06-05 | 2014-03-11 | Ajinomoto Co., Inc. | Emulsifying preparation |
WO2010140686A1 (en) | 2009-06-05 | 2010-12-09 | 味の素株式会社 | Emulsifying preparation |
JP2011167072A (en) * | 2010-01-21 | 2011-09-01 | Mitsubishi Rayon Co Ltd | Method for producing ester compound |
KR20210042013A (en) * | 2019-10-07 | 2021-04-16 | 동국대학교 산학협력단 | Novel preservatives and preparation method thereof |
WO2021071136A3 (en) * | 2019-10-07 | 2021-06-10 | 동국대학교 산학협력단 | Novel preservative, and method for producing same |
KR102419005B1 (en) * | 2019-10-07 | 2022-07-11 | 동국대학교 산학협력단 | Novel preservatives and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP3092006B1 (en) | 2000-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3092006B1 (en) | Synthesis method of new capsaicinoid-like substance | |
Halldorsson et al. | Chemoenzymatic synthesis of structured triacylglycerols by highly regioselective acylation | |
JP4043605B2 (en) | Method for producing capsaicin analogs | |
JPH0591888A (en) | Production of omega-9 highly unsaturated faitty acid and lipid containing the same | |
US6617141B1 (en) | Enzymatic process for preparing reduced-calorie fats containing behenic acid | |
EP0666925B1 (en) | Enzymic triglyceride conversion | |
JP5667050B2 (en) | Enzymatic synthesis of acetoacetate esters and derivatives | |
JP2018154559A (en) | Method for isolating r-isomer of 3 hydroxy butyric acid ester | |
JPH0730352B2 (en) | Enzymatic purification of fats and oils | |
JP2545480B2 (en) | Functional food material | |
JP2779774B2 (en) | Method for selective acylation of steryl glycosides | |
JP3638643B2 (en) | Process for producing optically active 1-octen-3-ol | |
JPH02219598A (en) | Optically active compound and production thereof | |
JP2726114B2 (en) | Process for producing optically active 3-chloro-1,2-propanediol and its esters | |
JP3583798B2 (en) | Method for producing optically active 2-methylbutanoic acid and derivatives thereof | |
JP2002171994A (en) | Method for producing optically active tetrahydrofuran-2-carboxylic acid or its antipode ester | |
EP0422768B1 (en) | Optically active monoester compounds and producing same | |
JP4547470B2 (en) | Optically active glycerol diricinoleate and process for producing the same | |
JP7252350B2 (en) | Method for producing lipids containing structural units based on glycerides of hydroxycarboxylic acids | |
Nicotra et al. | ω-Functionalized Esters by Enzymatic Acylation | |
JP2736075B2 (en) | Process for producing optically active 1,3-butanediol-1-benzyl ether and derivatives thereof | |
JPH02107195A (en) | Production of lysophospholipid | |
JP2001169794A (en) | Method for purifying conjugated linoleic acid isomer | |
JPH0253498A (en) | Enzymatic resolution of optical isomer of racemic ester derivative of 3-mercapto-2-alkyl- propionic acid | |
JPH069501A (en) | Optically active 2-alkoxycarbonyl-2-cycloalkene derivative and its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080728 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090728 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100728 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100728 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100728 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110728 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110728 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120728 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120728 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130728 Year of fee payment: 13 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |